Immunocompromised adults show weaker response to RSV vaccines
Johns Hopkins Medicine researchers have shown that people 60 years or older with weakened immunity -; primarily organ transplant recipients ...
Tag: Micrograph
Bacteria modify their ribosomes in response to the antibiotics
Bacteria modify their ribosomes when exposed to widely used antibiotics, according to research published today in Nature Communications. The subtle ...
NIAID awards grants for 10 projects to improve diagnostic tools for syphilis
The National Institutes of Health's National Institute of Allergy and Infectious Diseases (NIAID) has awarded grants for 10 projects to ...
Inhalable point-of-care urinary diagnostic platform for early lung cancer detection
Using a new technology developed at MIT, diagnosing lung cancer could become as easy as inhaling nanoparticle sensors and then ...
Severe COVID-19 may cause long-term changes to innate immune system
Severe COVID-19 may cause long-lasting alterations to the innate immune system, the first line of defense against pathogens, according to ...
NIAID awards more than $12 million for the development of antiviral therapies
The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, recently awarded more than ...
Research sheds light on specific protein interaction that could provide new treatment strategy to combat Cholera
Bacterial infectious diseases are still a huge contributor to global disease burden and with antibiotic resistance on the rise worldwide ...
Clinical trial to evaluate antiviral drug for monkeypox begins in the Democratic Republic of the Congo
A clinical trial to evaluate the antiviral drug tecovirimat, also known as TPOXX, in adults and children with monkeypox has ...
Impaired immune responses not responsible for COVID-19 rebound, findings suggest
Findings from a small study of eight patients published in Clinical Infectious Diseases suggest that COVID-19 rebound is likely not ...
UW Medicine researchers seek participants for Phase 3 clinical trial of a drug to treat monkeypox
UW Medicine researchers are recruiting participants for a Phase 3 clinical trial of a drug to treat the monkeypox virus. ...
